Laura Badami, NP
Nurse Practitioner · Independence, MONPI 1386205961
Payments from drug & device makers
Across 627 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$3K
- E.r. Squibb & Sons, L.L.C.$875
- Lilly USA, LLC$820
- Pfizer$673
- Dermavant Sciences, Inc.$579
- plus $4K from 25 others
What the payments were for
- Consulting fees$8507%
- Travel & lodging$310%
- Food & beverage$11,09687%
- Education$7246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 106 | $3,279 |
| AbbVie | 156 | $2,706 |
| E.r. Squibb & Sons, L.L.C. | 50 | $875 |
| Lilly USA, LLC | 62 | $820 |
| Pfizer | 32 | $673 |
| Dermavant Sciences, Inc. | 52 | $579 |
| UCB, Inc. | 22 | $496 |
| Sun Pharmaceutical Industries Inc. | 16 | $384 |
| Regeneron Healthcare Solutions, Inc. | 12 | $349 |
| Novartis | 15 | $344 |
| Sanofi | 11 | $277 |
| Galderma Laboratories, L.p. | 8 | $207 |
| Incyte Corporation | 11 | $201 |
| Amgen | 8 | $191 |
| Organon | 13 | $190 |
| Arcutis Biotherapeutics, Inc. | 14 | $177 |
| LEO Pharma Inc. | 8 | $147 |
| Mayne Pharma Commercial LLC | 7 | $136 |
| GSK | 1 | $114 |
| Almirall LLC | 4 | $98 |
| AstraZeneca | 1 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Boehringer Ingelheim | 3 | $64 |
| Kyowa Kirin, Inc. | 3 | $46 |
| Biofrontera Inc. | 3 | $43 |
| Kerecis Limited | 3 | $40 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Revance Therapeutics, Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Mylan Institutional Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,701 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 23 | $351,981 |
| Dupixent PenDupilumab | 20 | $83,198 |
| Ketoconazole | 360 | $5,336 |
| Clobetasol Propionate | 84 | $3,697 |
| Doxycycline Hyclate | 116 | $3,082 |
| Betamethasone Dipropionate | 59 | $2,986 |
| Finasteride | 156 | $1,548 |
| Calcipotriene | 12 | $1,438 |
| Minoxidil | 174 | $1,357 |
| Tretinoin | 16 | $1,330 |
| Tacrolimus | 15 | $1,298 |
| Dutasteride | 28 | $1,047 |
| Triamcinolone Acetonide | 140 | $781 |
| Clindamycin Phosphate | 14 | $729 |
| Metronidazole | 12 | $589 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Independence
- Vadsana SmithIndependence$12K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.